{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:20:52Z","timestamp":1789791652020,"version":"4.0.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.transproceed.2025.06.019","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T11:22:26Z","timestamp":1754997746000},"page":"1329-1333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tacrolimus Toxicity Induced by Nirmatrelvir\/Ritonavir in a Renal Transplant Recipient Managed With Phenytoin: A Case Report and Literature Review"],"prefix":"10.1016","volume":"57","author":[{"given":"Ching-Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6119-0587","authenticated-orcid":false,"given":"Shang-Feng","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2025.06.019_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2023.100529","article-title":"A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir\/ritonavir in a kidney transplant patient with COVID-19","volume":"53","author":"Tomida","year":"2023","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.transproceed.2025.06.019_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1364121","article-title":"Case report and literature review: management of Paxlovid (nirmatrelvir\/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus","volume":"15","author":"Jiang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.transproceed.2025.06.019_bib0003","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future","volume":"35","author":"de Mattos","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.transproceed.2025.06.019_bib0004","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 3","key":"10.1016\/j.transproceed.2025.06.019_bib0005","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1093\/clinids\/5.Supplement_3.S440","article-title":"Adverse effects of rifampin","volume":"5","author":"Grosset","year":"1983","journal-title":"Rev Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.transproceed.2025.06.019_bib0006","first-page":"S71","article-title":"Clinically significant carbamazepine drug interactions: an overview","volume":"28","author":"Pippenger","year":"1987","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.transproceed.2025.06.019_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.transproceed.2025.06.019_bib0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/dmd.107.017418","article-title":"HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.transproceed.2025.06.019_bib0009","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.clpt.6100431","article-title":"Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and pgp as assessed by probe substrates midazolam, caffeine, and digoxin","volume":"84","author":"Magnusson","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.transproceed.2025.06.019_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13181-022-00922-2","article-title":"Tacrolimus drug-drug interaction with Nirmatrelvir\/Ritonavir (Paxlovid\u2122) managed with Phenytoin","volume":"19","author":"Sindelar","year":"2023","journal-title":"J Med Toxicol"},{"issue":"3","key":"10.1016\/j.transproceed.2025.06.019_bib0011","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/ki.1993.101","article-title":"Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion","volume":"43","author":"Ruggenenti","year":"1993","journal-title":"Kidney Int"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134525003665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134525003665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:07:19Z","timestamp":1758737239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134525003665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0041134525003665"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.06.019","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacrolimus Toxicity Induced by Nirmatrelvir\/Ritonavir in a Renal Transplant Recipient Managed With Phenytoin: A Case Report and Literature Review","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2025.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}